News

Search:  

Regulatory Update | 21 May 2012

Brazil: Anivsa Sets Confidentiality Criteria

0 Likes

A notice (Ordinance No. 748-B/2012) published by Anvisa on 18 May sets forth the criteria the agency will use for classifying materials as confidential and thus ineligible for release under the Access [Read More...]


Regulatory Update | 21 May 2012

Brazil: Anivsa Implements Freedom of Information Law

0 Likes

Greater transparency is an integral part of the reorganization of Brazil’s national regulatory agency, Anvisa, and the agency will now release upon written request copies of all documents in its [Read More...]


Latest News | 2 May 2012

FDA Disputes Study Findings, Goes After Some Clinical Trial Sponsors

0 Likes

Months after the British Medical Journal (BMJ) reported that the US Food and Drug Administration’s (FDA) oversight of its clinical trials database was suffering from serious lapses in clinical trial [Read More...]


Latest News | 19 April 2012

Legislation to Make FDA’s Regulatory Calculus More Transparent Introduced in Congress

0 Likes

Sens. Richard Burr (R-NC) and Tom Coburn (R-OK) introduced legislation that would reform the US Food and Drug Administration’s (FDA) regulatory transparency by mandating the agency submit to Congress [Read More...]


Latest News | 6 February 2012

Proposed Bill Would Limit Use of Consent Decrees, Settlement Agreements

0 Likes

A bill introduced in the US House of Representatives by Reps. Ben Quayle (R-AZ), Dennis Ross (R-FL) and Howard Coble (R-CA) would place “limitations on consent decrees and settlement agreements by [Read More...]


Latest News | 4 January 2012

BMJ: Lack of Research Transparency Breaks Regulations, Hurts Patients

0 Likes

A series of studies published this week in the British Medical Journal by groups of researchers from various universities have found serious lapses in clinical trial reporting and transparency.Among [Read More...]